An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma
Mark Kalinich(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), David T. Miyamoto(Broad Institute), David T. Ting(Massachusetts General Hospital), Alona Muzikansky(Johns Hopkins University), Xin Hong(Southern University of Science and Technology), John Milner(National Cancer Institute), Huidan Zhang(Qilu Hospital of Shandong University), Ravi Kapur(Harvard University), Raymond T. Chung(Harvard University), David A. Weitz(Harvard University), Uyen Ho(Harvard University), Irun Bhan(Harvard University), Melissa Choz(Massachusetts General Hospital), Lipika Goyal(Harvard University), Joseph A. LiCausi(Harvard University), Shyamala Maheswaran(Massachusetts General Hospital), David P. Ryan(Johns Hopkins University), Lecia V. Sequist(Harvard University), Mehmet Toner(Shriners Hospitals for Children - Erie), Kurt J. Isselbacher(Harvard University), Srinjoy Sil(Massachusetts General Hospital), Sarah Javaid(Harvard University), Andrew X. Zhu(Massachusetts General Hospital), Tanya T. Kwan(Howard Hughes Medical Institute)
Cited by 157
Related Papers
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k